The Prognostic Significance of the Depth of Cervical Stromal Invasion in Women With FIGO Stage II Uterine Endometrioid Carcinoma

被引:3
作者
Al Khatib, Sondos [1 ]
Bhatnagar, Aseem [1 ]
Elshaikh, Noor [1 ]
Ghanem, Ahmed I. [1 ,5 ]
Burmeister, Charlotte [2 ]
Allo, Ghassan [3 ]
Alkamachi, Bassam [3 ]
Paridon, Alex [4 ]
Elshaikh, Mohamed A. [1 ]
机构
[1] Henry Ford Canc Inst, Dept Radiat Oncol, 2800 W Grand Blvd, Detroit, MI 48202 USA
[2] Henry Ford Canc Inst, Dept Publ Hlth, Detroit, MI 48202 USA
[3] Henry Ford Canc Inst, Dept Pathol, Detroit, MI 48202 USA
[4] Henry Ford Canc Inst, Dept Womens Hlth Serv, Div Gynecol Oncol, Detroit, MI 48202 USA
[5] Alexandria Univ, Alexandria Clin Oncol Dept, Fac Med, Alexandria, Egypt
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2023年 / 46卷 / 10期
关键词
endometrial carcinoma; stage II; cervical stromal invasion; adjuvant; hysterectomy; prognosis; CANCER; RECURRENCE; SURVIVAL; BRACHYTHERAPY; RADIOTHERAPY; INTERVAL;
D O I
10.1097/COC.0000000000001033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The objective of this study was to investigate the prognostic significance of the depth of cervical stromal invasion (CSI) in women with FIGO stage II uterine endometrioid adenocarcinoma (EC).Methods: Our database of women with EC was quired for patients with stage II EC. Pathologic slides were retrieved and reviewed by gynecologic pathologists to determine cervical stromal thickness and depth of CSI as a percentage of stromal thickness (%CSI). Kaplan-Meier, univariate, and multivariate analyses were used to compare recurrence-free, disease-specific (DSS), and overall survival (OS) between women who had<50% versus = 50% CSI. Univariate and multivariate analyses were used to assess other prognostic variables associated with survival endpoints.Results: A total of 117 patients were included in our study who had hysterectomy between 1/1990 and 8/2021. Seventy-nine patients (68%) with <50% and 38 (32w%) with = 50% CSI. After a median follow-up of 131 months, 5-year DSS was significantly worse for women with = 50% CSI (78% vs. 91%; P=0.04). However, %CSI was not an independent predictor for any of the studied survival endpoints. Independent predictors of worse 5-year recurrence-free survival and DSS included FIGO grade 3 tumors (P=0.02) and the presence of lymphovascular space invasion (P=0.03). Grade 3 tumors were the only independent predictor of worse 5-year OS (P=0.02).Conclusions: Our results suggest that deep CSI is not an independent prognostic factor for survival endpoints in women with stage II uterine endometroid adenocarcinoma. The lack of independent prognostic significance of the depth CSI needs to be validated in a multi-institutional analysis.
引用
收藏
页码:445 / 449
页数:5
相关论文
共 50 条
[21]   Histologic study of patterns of cervical involvement in FIGO stage II endometrial carcinoma [J].
Scurry, J ;
Craighead, P ;
Duggan, M .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2000, 10 (06) :497-502
[22]   The impact of lymphadenectomy on survival endpoints in women with early stage uterine endometrioid carcinoma: A matched analysis [J].
Ghanem, Ahmed I. ;
Khan, Nadia T. ;
Mahan, Meredith ;
Ibrahim, Ahmed ;
Buekers, Thomas ;
Elshaikh, Mohamed A. .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 210 :225-230
[23]   Stage II recurrent nasopharyngeal carcinoma: Prognostic significance of retropharyngeal nodal metastasis, parapharyngeal invasion, and carotid encasement [J].
Chan, Jimmy Yu Wai ;
Wong, Stanley Thian Sze ;
Wei, William Ignace .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (01) :103-110
[24]   Comparison of the Prognoses of FIGO Stage I to Stage II Adenosquamous Carcinoma and Adenocarcinoma of the Uterine Cervix Treated With Radical Hysterectomy [J].
Mabuchi, Seiji ;
Okazawa, Mika ;
Kinose, Yasuto ;
Matsuo, Koji ;
Fujiwara, Masateru ;
Suzuki, Osamu ;
Morii, Eiichi ;
Kamiura, Shoji ;
Ogawa, Kazuhiko ;
Kimura, Tadashi .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (08) :1389-1397
[25]   The prognostic significance of hematological parameters in women with uterine serous papillary carcinoma (USPC) [J].
Younes, Grace ;
Segev, Yakir ;
Begal, Julia ;
Auslender, Ron ;
Goldberg, Yael ;
Amit, Amnon ;
Lavie, Ofer .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2016, 199 :16-20
[26]   The Relationship Between ERCC1 Expression and Clinical Outcome in Patients With FIGO Stage I to Stage II Uterine Cervical Adenocarcinoma [J].
Hasegawa, Kiyoshi ;
Kato, Rina ;
Torii, Yutaka ;
Ichikawa, Ryoko ;
Oe, Shuko ;
Udagawa, Yasuhiro .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (08) :1479-1485
[27]   The Prognostic Value of Preoperative Serum CA125 in Endometrioid Endometrial Cancer with Cervical Stromal and Parametrial Invasion [J].
Ashrafganjoei, Tahereh ;
Bahman, Atieh ;
Hosseini, Maryam Sadat ;
Arab, Maliheh ;
Farzaneh, Farah ;
Moridi, Atefeh ;
Faghih, Nafiseh ;
Sohrabi, Somayeh .
INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2019, 12 (10) :1-7
[28]   Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma [J].
Ruz-Caracuel, Ignacio ;
Lopez-Janeiro, Alvaro ;
Heredia-Soto, Victoria ;
Ramon-Patino, Jorge L. ;
Yebenes, Laura ;
Berjon, Alberto ;
Hernandez, Alicia ;
Gallego, Alejandro ;
Ruiz, Patricia ;
Redondo, Andres ;
Pelaez-Garcia, Alberto ;
Mendiola, Marta ;
Hardisson, David .
VIRCHOWS ARCHIV, 2021, 479 (06) :1167-1176
[29]   Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer [J].
Matsuo, Koji ;
Yabuno, Akira ;
Hom, Marianne S. ;
Shida, Masako ;
Kakuda, Mamoru ;
Adachi, Sosuke ;
Mandelbaum, Rachel S. ;
Ueda, Yutaka ;
Hasegawa, Kosei ;
Enomoto, Takayuki ;
Mikami, Mikio ;
Roman, Lynda D. .
GYNECOLOGIC ONCOLOGY, 2018, 149 (02) :301-309
[30]   Adjuvant Pelvic Radiation Therapy ± Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma [J].
Nagar, Himanshu ;
Yan, Weisi ;
Parashar, Bhupesh ;
Nori, Dattatreyudu ;
Chao, K. S. C. ;
Christos, Paul ;
Gupta, Divya ;
Holcomb, Kevin ;
Caputo, Thomas ;
Wernicke, A. Gabriella .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (04) :335-339